Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mark Bolstridge is active.

Publication


Featured researches published by Mark Bolstridge.


The Journal of Neuroscience | 2013

Broadband Cortical Desynchronization Underlies the Human Psychedelic State

Suresh Daniel Muthukumaraswamy; Robin L. Carhart-Harris; Rosalyn J. Moran; Matthew J. Brookes; Tim M. Williams; David Errtizoe; Ben Sessa; A. Papadopoulos; Mark Bolstridge; Krish Devi Singh; Amanda Feilding; K. J. Friston; David Nutt

Psychedelic drugs produce profound changes in consciousness, but the underlying neurobiological mechanisms for this remain unclear. Spontaneous and induced oscillatory activity was recorded in healthy human participants with magnetoencephalography after intravenous infusion of psilocybin—prodrug of the nonselective serotonin 2A receptor agonist and classic psychedelic psilocin. Psilocybin reduced spontaneous cortical oscillatory power from 1 to 50 Hz in posterior association cortices, and from 8 to 100 Hz in frontal association cortices. Large decreases in oscillatory power were seen in areas of the default-mode network. Independent component analysis was used to identify a number of resting-state networks, and activity in these was similarly decreased after psilocybin. Psilocybin had no effect on low-level visually induced and motor-induced gamma-band oscillations, suggesting that some basic elements of oscillatory brain activity are relatively preserved during the psychedelic experience. Dynamic causal modeling revealed that posterior cingulate cortex desynchronization can be explained by increased excitability of deep-layer pyramidal neurons, which are known to be rich in 5-HT2A receptors. These findings suggest that the subjective effects of psychedelics result from a desynchronization of ongoing oscillatory rhythms in the cortex, likely triggered by 5-HT2A receptor-mediated excitation of deep pyramidal cells.


Proceedings of the National Academy of Sciences of the United States of America | 2016

Neural correlates of the LSD experience revealed by multimodal neuroimaging

Robin L. Carhart-Harris; Suresh Daniel Muthukumaraswamy; Leor Roseman; Mendel Kaelen; W. Droog; Kieran C. Murphy; Enzo Tagliazucchi; E.E. Schenberg; T. Nest; Csaba Orban; Robert Leech; L.T. Williams; Tim M. Williams; Mark Bolstridge; B. Sessa; John McGonigle; Martin I. Sereno; David E. Nichols; Peter J. Hellyer; Peter Hobden; John Evans; Krish Devi Singh; Richard Geoffrey Wise; H.V. Curran; Amanda Feilding; David Nutt

Significance Lysergic acid diethylamide (LSD), the prototypical “psychedelic,” may be unique among psychoactive substances. In the decades that followed its discovery, the magnitude of its effect on science, the arts, and society was unprecedented. LSD produces profound, sometimes life-changing experiences in microgram doses, making it a particularly powerful scientific tool. Here we sought to examine its effects on brain activity, using cutting-edge and complementary neuroimaging techniques in the first modern neuroimaging study of LSD. Results revealed marked changes in brain blood flow, electrical activity, and network communication patterns that correlated strongly with the drug’s hallucinatory and other consciousness-altering properties. These results have implications for the neurobiology of consciousness and for potential applications of LSD in psychological research. Lysergic acid diethylamide (LSD) is the prototypical psychedelic drug, but its effects on the human brain have never been studied before with modern neuroimaging. Here, three complementary neuroimaging techniques: arterial spin labeling (ASL), blood oxygen level-dependent (BOLD) measures, and magnetoencephalography (MEG), implemented during resting state conditions, revealed marked changes in brain activity after LSD that correlated strongly with its characteristic psychological effects. Increased visual cortex cerebral blood flow (CBF), decreased visual cortex alpha power, and a greatly expanded primary visual cortex (V1) functional connectivity profile correlated strongly with ratings of visual hallucinations, implying that intrinsic brain activity exerts greater influence on visual processing in the psychedelic state, thereby defining its hallucinatory quality. LSD’s marked effects on the visual cortex did not significantly correlate with the drug’s other characteristic effects on consciousness, however. Rather, decreased connectivity between the parahippocampus and retrosplenial cortex (RSC) correlated strongly with ratings of “ego-dissolution” and “altered meaning,” implying the importance of this particular circuit for the maintenance of “self” or “ego” and its processing of “meaning.” Strong relationships were also found between the different imaging metrics, enabling firmer inferences to be made about their functional significance. This uniquely comprehensive examination of the LSD state represents an important advance in scientific research with psychedelic drugs at a time of growing interest in their scientific and therapeutic value. The present results contribute important new insights into the characteristic hallucinatory and consciousness-altering properties of psychedelics that inform on how they can model certain pathological states and potentially treat others.


Biological Psychiatry | 2015

The Effects of Acutely Administered 3,4-Methylenedioxymethamphetamine on Spontaneous Brain Function in Healthy Volunteers Measured with Arterial Spin Labeling and Blood Oxygen Level-Dependent Resting State Functional Connectivity

Robin L. Carhart-Harris; Kevin Murphy; Robert Leech; David Erritzoe; Matthew B. Wall; Bart Ferguson; Luke T.J. Williams; Leor Roseman; Stefan Brugger; Ineke De Meer; Mark A. Tanner; Robin J. Tyacke; Kim Wolff; Ajun Sethi; Michael A.P. Bloomfield; Tim M. Williams; Mark Bolstridge; Lorna Stewart; Celia J. A. Morgan; Rexford D. Newbould; Amanda Feilding; H. Val Curran; David J. Nutt

Background The compound 3,4-methylenedioxymethamphetamine (MDMA) is a potent monoamine releaser that produces an acute euphoria in most individuals. Methods In a double-blind, placebo-controlled, balanced-order study, MDMA was orally administered to 25 physically and mentally healthy individuals. Arterial spin labeling and seed-based resting state functional connectivity (RSFC) were used to produce spatial maps displaying changes in cerebral blood flow (CBF) and RSFC after MDMA administration. Participants underwent two arterial spin labeling and two blood oxygen level–dependent scans in a 90-minute scan session; MDMA and placebo study days were separated by 1 week. Results Marked increases in positive mood were produced by MDMA. Decreased CBF only was observed after MDMA, and this was localized to the right medial temporal lobe (MTL), thalamus, inferior visual cortex, and the somatosensory cortex. Decreased CBF in the right amygdala and hippocampus correlated with ratings of the intensity of global subjective effects of MDMA. The RSFC results complemented the CBF results, with decreases in RSFC between midline cortical regions, the medial prefrontal cortex, and MTL regions, and increases between the amygdala and hippocampus. There were trend-level correlations between these effects and ratings of intense and positive subjective effects. Conclusions The MTLs appear to be specifically implicated in the mechanism of action of MDMA, but further work is required to elucidate how the drug’s characteristic subjective effects arise from its modulation of spontaneous brain activity.


Scientific Reports | 2017

Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms

Robin L. Carhart-Harris; Leor Roseman; Mark Bolstridge; Lysia Demetriou; J. Nienke Pannekoek; Matthew B. Wall; Mark Tanner; Mendel Kaelen; John McGonigle; Kevin Murphy; Robert Leech; H. Valerie Curran; David J. Nutt

Psilocybin with psychological support is showing promise as a treatment model in psychiatry but its therapeutic mechanisms are poorly understood. Here, cerebral blood flow (CBF) and blood oxygen-level dependent (BOLD) resting-state functional connectivity (RSFC) were measured with functional magnetic resonance imaging (fMRI) before and after treatment with psilocybin (serotonin agonist) for treatment-resistant depression (TRD). Quality pre and post treatment fMRI data were collected from 16 of 19 patients. Decreased depressive symptoms were observed in all 19 patients at 1-week post-treatment and 47% met criteria for response at 5 weeks. Whole-brain analyses revealed post-treatment decreases in CBF in the temporal cortex, including the amygdala. Decreased amygdala CBF correlated with reduced depressive symptoms. Focusing on a priori selected circuitry for RSFC analyses, increased RSFC was observed within the default-mode network (DMN) post-treatment. Increased ventromedial prefrontal cortex-bilateral inferior lateral parietal cortex RSFC was predictive of treatment response at 5-weeks, as was decreased parahippocampal-prefrontal cortex RSFC. These data fill an important knowledge gap regarding the post-treatment brain effects of psilocybin, and are the first in depressed patients. The post-treatment brain changes are different to previously observed acute effects of psilocybin and other ‘psychedelics’ yet were related to clinical outcomes. A ‘reset’ therapeutic mechanism is proposed.


European Neuropsychopharmacology | 2016

LSD modulates music-induced imagery via changes in parahippocampal connectivity

Mendel Kaelen; Leor Roseman; Joshua Kahan; Andre Santos-Ribeiro; Csaba Orban; Romy Lorenz; Frederick S. Barrett; Mark Bolstridge; Tim M. Williams; Luke Williams; Matthew B. Wall; Amanda Feilding; Suresh Daniel Muthukumaraswamy; David J. Nutt; Robin L. Carhart-Harris

Psychedelic drugs such as lysergic acid diethylamide (LSD) were used extensively in psychiatry in the past and their therapeutic potential is beginning to be re-examined today. Psychedelic psychotherapy typically involves a patient lying with their eyes-closed during peak drug effects, while listening to music and being supervised by trained psychotherapists. In this context, music is considered to be a key element in the therapeutic model; working in synergy with the drug to evoke therapeutically meaningful thoughts, emotions and imagery. The underlying mechanisms involved in this process have, however, never been formally investigated. Here we studied the interaction between LSD and music-listening on eyes-closed imagery by means of a placebo-controlled, functional magnetic resonance imaging (fMRI) study. Twelve healthy volunteers received intravenously administered LSD (75µg) and, on a separate occasion, placebo, before being scanned under eyes-closed resting conditions with and without music-listening. The parahippocampal cortex (PHC) has previously been linked with (1) music-evoked emotion, (2) the action of psychedelics, and (3) mental imagery. Imaging analyses therefore focused on changes in the connectivity profile of this particular structure. Results revealed increased PHC-visual cortex (VC) functional connectivity and PHC to VC information flow in the interaction between music and LSD. This latter result correlated positively with ratings of enhanced eyes-closed visual imagery, including imagery of an autobiographical nature. These findings suggest a plausible mechanism by which LSD works in combination with music listening to enhance certain subjective experiences that may be useful in a therapeutic context.


Neuropsychologia | 2016

A placebo-controlled investigation of synaesthesia-like experiences under LSD

Devin Blair Terhune; David Luke; Mendel Kaelen; Mark Bolstridge; Amanda Feilding; David J. Nutt; Robin L. Carhart-Harris; Jamie Ward

The induction of synaesthesia in non-synaesthetes has the potential to illuminate the mechanisms that contribute to the development of this condition and the shaping of its phenomenology. Previous research suggests that lysergic acid diethylamide (LSD) reliably induces synaesthesia-like experiences in non-synaesthetes. However, these studies suffer from a number of methodological limitations including lack of a placebo control and the absence of rigorous measures used to test established criteria for genuine synaesthesia. Here we report a pilot study that aimed to circumvent these limitations. We conducted a within-groups placebo-controlled investigation of the impact of LSD on colour experiences in response to standardized graphemes and sounds and the consistency and specificity of grapheme- and sound-colour associations. Participants reported more spontaneous synaesthesia-like experiences under LSD, relative to placebo, but did not differ across conditions in colour experiences in response to inducers, consistency of stimulus-colour associations, or in inducer specificity. Further analyses suggest that individual differences in a number of these effects were associated with the propensity to experience states of absorption in ones daily life. Although preliminary, the present study suggests that LSD-induced synaesthesia-like experiences do not exhibit consistency or inducer-specificity and thus do not meet two widely established criteria for genuine synaesthesia.


Language, cognition and neuroscience | 2016

Semantic activation in LSD: evidence from picture naming

Neiloufar Family; David P. Vinson; Gabriella Vigliocco; Mendel Kaelen; Mark Bolstridge; David Nutt; Robin L. Carhart-Harris

ABSTRACT Lysergic acid diethylamide (LSD) is a classic psychedelic drug that alters cognition in a characteristic way. It has been suggested that psychedelics expand the breadth of cognition via actions on the central nervous system. Previous work has shown changes in semantic processing under psilocybin (a related psychedelic to LSD) that are consistent with an increased spread of semantic activation. The present study investigates this further using a picture-naming task and the psychedelic, LSD. Ten participants completed the task under placebo and LSD. Results revealed significant effects of LSD on accuracy and error correction that were consistent with an increased spread of semantic activation under LSD. These results are consistent with a generalised “entropic” effect on the mind. We suggest incorporating direct neuroimaging measures in future studies, and to employ more naturalistic measures of semantic processing that may enhance ecological validity.


The Lancet Psychiatry | 2015

Tomorrow never knows

Mark Bolstridge

We use whatever facts we have as knowledge. In addition to the facts, we make assumptions based on the facts, and treat these assumptions as knowledge. Such knowledge is effective when we adapt to the environment, even though it is not certain. For instance, we can do a conversation smoothly, by doing conjecture of the sense of values of the partner. Even when the conjecture may fail, it gives us the opportunity to try to know each other and advance the conversation smoothly after all. This is similar even in the conversation between human and systems. This pattern language describes how we profit from such conjectures. Since the pattern language handles relatively abstract matters, we put the Context and Resulting Context in a form of examples and we use stock keeping scenarios as an example case to explain its context in more concrete manner to help the readers understand. Note that the focal point of the patterns is not about stock keeping, but about the way to cope with uncertainty, or our ignorance. Lets start from the simplest form of the conjecture. The patterns described in this chapter show how to make assumptions based on complete, but difficult to derive, information.


The Lancet Psychiatry | 2016

Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study

Robin L. Carhart-Harris; Mark Bolstridge; Camilla M J Day; David Erritzoe; Mendel Kaelen; Michael Bloomfield; James Rickard; Ben Forbes; Amanda Feilding; David Taylor; Steve Pilling; Valerie Curran; David Nutt


Current Biology | 2016

Increased Global Functional Connectivity Correlates with LSD-Induced Ego Dissolution

Enzo Tagliazucchi; Leor Roseman; Mendel Kaelen; Csaba Orban; Suresh Daniel Muthukumaraswamy; Kevin Murphy; Helmut Laufs; Robert Leech; John McGonigle; Nicolas Crossley; Edward T. Bullmore; Timothy J. Williams; Mark Bolstridge; Amanda Feilding; David J. Nutt; Robin L. Carhart-Harris

Collaboration


Dive into the Mark Bolstridge's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

David Nutt

Imperial College London

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Leor Roseman

Imperial College London

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Robert Leech

Imperial College London

View shared research outputs
Researchain Logo
Decentralizing Knowledge